Anticonvulsant activity and interactions with neuronal voltage- dependent sodium channel of analogues of ameltolide

Journal of Medicinal Chemistry

Volumn 41, Issue 18, 1998, Pages 3307-3313

  Vamecq, Joseph ^a   Lambert, Didier ^b   Poupaert, Jacques H ^b   Masereel, Bernard ^c   Stables, James P ^d  

^a INSERM   (France)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMELTOLIDE; ANTICONVULSIVE AGENT; BENZAMIDE DERIVATIVE; PENTETRAZOLE; PHENYLTHIOUREA; PHENYTOIN; PHTHALIMIDE DERIVATIVE; SODIUM CHANNEL;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMALS; ANTICONVULSANTS; BATRACHOTOXINS; BENZAMIDES; BINDING, COMPETITIVE; BRAIN; ELECTROSHOCK; INJECTIONS, INTRAPERITONEAL; ION CHANNEL GATING; MICE; RATS; SEIZURES; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTOSOMES;

EID: 0032572830     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9608772     Document Type: Article

References (40)

1. Merritt, H. H.; Putnam, T. J. Experimental determination of the anticonvulsant properties of some phenyl derivatives. Science 1937, 85, 525-526.
2. Merritt, H. H.; Putnam, T. J. Sodium diphenyl hydantoinate in the treatment of convulsive disorders. J. Am. Med. Assoc. 1938, 111, 1068-1073.
3. Macdonald, R. L. Antiepileptic drug actions. Epilepsia 1989, 30, S19-S28.
4. Macdonald, R. L.; Kelly, K. M. Antiepileptic drug mechanisms of action. Epilepsia 1995, 36 (Suppl. 2), S2-S12.
5. Leppik, I. E. Felbamate. Epilepsia 1995, 36 (Suppl. 2), S66-S72.
6. McLean, M. J. Gabapentin. Epilepsia 1995, 36 (Suppl. 2), S73-S86.
7. Messenheimer, J. A. Lamotrigine. Epilepsia 1995, 36 (Suppl. 2), S87-S94.
8. Fisher, R.; Blum D. Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs of action. Epilepsia 1995, 36 (Suppl. 2), S105-S114.
9. Torchin, C. D.; McNeilly, P. J.; Kapetanovic, I. M.; Strong, J. M.; Kupferberg, H. J. Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes. Drug Metab. Dispos. 1996, 24, 1002-1008.
10. Wamil, A. W.; Cheung, H.; Harris, E. W.; McLean, M. J. Remacemide HCl and its metabolite, FPL12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture. Epilepsy Res. 1996, 23, 1-14.
11. Kapetanovic, I. M.; Rundfeldt, C. D-23129: a new anticonvulsant compound. CNS Drug Rev. 1996, 2, 308-321.
12. Clark, C. R.; Wells, M. J. M.; Sansom, R. T.; Norris, G. N.; Dockens, R. C.; Ravis, W. R. Anticonvulsant activity of some 4-aminobenzamides. J. Med. Chem. 1984, 27, 779-782.
13. Clark, C. R.; Sansom, R. T.; Lin, C. M.; Norris, G. N. Anticonvulsant activity of some 4-aminobenzanilides. J. Med. Chem. 1985, 28, 1259-1262.
14. Clark, C. R.; Lin, C. M.; Sansom, R. T. Anticonvulsant activity of 2- and 3-aminobenzanilides. J. Med. Chem. 1986, 29, 1534-1537.
15. Clark, C. R.; Davenport, T. W. Synthesis and anticonvulsant activity of analogues of 4-amino-N-(1-phenylethyl)benzamide. J. Med. Chem. 1987, 30, 1214-1218.
16. Clark C. R. Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylphenyl)benzamide and prototype antiepileptic drugs in mice and rats. Epilepsia 1988, 29, 198-203.
17. Leander, J. D.; Robertson, D. W.; Clark, C. R.; Lawson, R. R.; Rathbun, R. C. Pharmacological effects of enantiomers of 4-amino-N-(α-methylbenzyl)benzamide, a chemically novel anticonvulsant. Epilepsia 1988, 29, 83-90.
18. Leander, J. D.; Lawson, R. R.; Robertson, D. W. Anticonvulsant effects of a novel aminobenzamide (LY201116) in mice. Neuropharmacology 1988, 27, 623-628.
19. Bailleux, V.; Vallée, L.; Nuyts, J. P.; Vamecq, J. Anticonvulsant activity of some 4-amino-N-phenylphthalimides and N-(3-amino-2-methylphenyl)phthalimides. Biomed. Pharmacother. 1994, 48, 95-101.
20. Bailleux, V.; Vallée, L.; Nuyts, J. P.; Vamecq, J. Synthesis and anticonvulsant activity of some N-phenylphthalimides. Chem. Pharm. Bull. 1994, 42, 1817-1821.
21. Bailleux, V.; Vallée, L.; Nuyts, J. P.; Hamoir, G.; Poupaert, J. H.; Stables, J. P.; Vamecq, J. Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylphenyl)phthalimide and prototype antiepileptic drugs in mice and rats. Epilepsia 1995, 36, 559-565.
22. Poupaert, J.; Hamoir, G.; Barbeaux, P.; Lambert, D.; Hénichart, J. P. Anticonvulsant activity of some N-phenylphthalimide derivatives in rats and mice. J. Pharm. Pharmacol. 1995, 47, 89-91.
23. Willow, M.; Catterall, W. A. Inhibition of binding of [3H]-batrachotoxinin A 20-α-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol. Pharmacol. 1982, 22, 627-635.
24. Francis, J.; Burnham, W. M. [3H] Phenytoin identifies a novel anticonvulsant-binding domain on voltage-dependent sodium channels. Mol. Pharmacol. 1992, 42, 1097-1103.
25. Brown, G. B. Batrachotoxin, a window on the allosteric nature of the voltage-sensitive sodium channels. Int. Rev. Neurobiol. 1988, 29, 77-116.
26. Fischer, W.; Bodewei, R.; Satzinger, G. Anticonvulsant and sodium channel blocking effects of ralitoline in different screening models. Naunyn-Schmiedebergs Arch. Pharmakol. 1992, 346, 442-452.
27. Meldrum, B. S. Lamotrigin: a novel approach. Seizure 1994, 3 (Suppl. A), 41-45.
28. Zhu, Y.; Im, W. B.; Lewis, R. A.; Althaus, J. S.; Cazers, A. R.; Nielsen, J. W.; Palmer, J. R.; Von Voigtlander, P. F. Two metabolites of anticonvulsant U-54494A: their anticonvulsant activity and interaction with sodium channel. Brain Res. 1993, 606, 50-55.
29. Trainer, V. L.; Moreau, E.; Guedin, D.; Baden, D. G.; Catterall, W. A. Neurotoxin binding and allosteric modulation at receptor site 2 and 5 purified and reconstituted rat brain sodium channels. J. Biol. Chem. 1993, 268, 17114-17119.
30. Catterall, W. Structure and function of voltage-sensitive ion channels. Science 1988, 242, 50-62.
31. Parli, C. J.; Evenson, E.; Potts, B. D.; Beedle, E.; Lawson, R.; Robertson, D. W.; Leander, J. D. Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-(diethylamino)acetylaminobenzamide) to the potent anticonvulsant LY 201116 in mice - Effect of bis-(p-nitrophenyl)phosphate. Drug Metab. Dispos. 1988, 16, 707-711.
32. Potts, B. D.; Steve, G.; Parli, C. J. Metabolism, disposition and pharmacokinetics of a potent anticonvulsant 4-amino-N-(2,6-dimethyl phenyl)benzamide (LY 201116) in rats. Drug Metab. Dispos. 1989, 17, 656-661.
33. Starks, L. G.; Albertson, T. E. The effects of LY-201116 [4-amino-N-(2,6-dimethylphenyl)benzamide] on the amygdala-kindled rat. Neuropharmacology 1990, 29, 1085-1089.
34. Engelhardt, J. A.; Parli, C. J.; Kovach, P. M.; Shoufler, J. R.; Emmerson, J. L.; Leander, J. D. Subchronic toxicity, metabolism and pharmacokinetics of the aminobenzamide anticonvulsant ameltolide (LY 201116) in Rhesus Monkeys. Fundam. Appl. Tox. 1992, 19, 197-201.
35. Leander, J. D. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116). Epilepsia 1992, 33, 573-576.
36. Krall, R. L.; Penry, J. K.; White, B. G.; Kupferberg, H. J.; Swinyard, E. A. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 1978, 19, 409-428.
37. Porter, R. J.; Cereghino, J. J.; Gladding, G. D.; Hessie, B. J.; Kupferberg, H. J.; Scoville, B.; White, B. G. Antiepileptic Drug Development Program. Cleve. Clin. Q. 1984, 51, 293-305.
38. Kupferberg, H. J. Antiepileptic Drug Development Program: A Cooperative Effort of Government and Industry. Epilepsia 1989, 30 (Suppl. 1), S51-S56.
39. Tamkun, M. M.; Catterall, W. A. Ion flux studies of voltage-sensitive sodium channels in synaptic nerve-ending particles. Mol. Pharmacol. 1980, 19, 78-86.
40. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.